A Product of Software Patents

Product Lifecycle Management Through Patents

Big pharma recognizes that new drug development is a high risk venture which takes a great deal of time, has an exceptionally low success rate, and in the case of a successful new drug development, ultimately has a price tag which is typically in excess $100 million dollars. In the face of stiff, aggressive generic competition, many brand name companies now have lifecycle management teams in pl...

Software Patents in Europe

This is only one small example of the fatal impact of ambiguous European regulations on software patents. European software industry faces an almost crushing competition from the United States and Japan. The competitors have been familiar with software patents for several years and are able to use the means of patent protection to reach their business goals. As long as the European software ind...

Software Patents Pending?

Recent twin decisions of the European Patent Office's Technical Board of Appeal have shifted its stance on software patents significantly. In this paper, I explore the background to this shift and suggest that the mindset to software patents enshrined in the Trade-Related Aspects of Intellectual Property Rights Agreement (TRIPS) is already being introduced ahead of formal amendment of the Europ...

Patents for software?

Software Patents Panel

Over 6000 patents were issued last year in the US for software related inventions. Patent protection is available for software developments in Australia, US and Europe in addition to copyright protection. However, little use of the system has been made in Australia. We review the different types of intellectual property systems, and the use of the patent system in Australia in relation to prote...